Rise Advisors, LLC Blueprint Medicines Corp Transaction History
Rise Advisors, LLC
- $187 Million
- Q2 2024
A detailed history of Rise Advisors, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Rise Advisors, LLC holds 156 shares of BPMC stock, worth $13,823. This represents 0.01% of its overall portfolio holdings.
Number of Shares
156
Previous 156
-0.0%
Holding current value
$13,823
Previous $14,000
14.29%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
340Shares Held
62MCall Options Held
987KPut Options Held
578K-
Black Rock Inc. New York, NY6.65MShares$589 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.54MShares$579 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.87MShares$520 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$287 Million0.06% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.46MShares$218 Million8.22% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.29B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...